Public procurement of biosimilar medicines in the National Health System

Reports on biosimilar medicines

November 30th 2021BioSim (EN)
The public purchase of biosimilars as an efficiency tool for the National Health System: challenges and recommendations.

OPEN REPORT OPEN EXECUTIVE SUMMARY watch video

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE